My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Clarivate Plc Ordinary Shares (NY:CLVT)

2.440 -0.100 (-3.94%)

Official Closing Price Updated: 7:00 PM EDT, May 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clarivate Plc Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Generative AI Startup AI21 Labs Reaches Unicorn Status With Latest Funding Round ↗

August 31, 2023

AI21 Labs, a front-runner in the AI domain specializing in large language models (LLMs), declared the completion of a $155 million Series C fundraiser.

Via Benzinga

Topics Artificial Intelligence

Where Clarivate Stands With Analysts ↗

August 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 ↗

August 25, 2023

Via Benzinga

12 Industrials Stocks Moving In Monday's After-Market Session ↗

August 21, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Clarivate ↗

July 05, 2023

Via Benzinga

Where Clarivate Stands With Analysts ↗

June 13, 2023

Via Benzinga

Analyst Expectations for Clarivate's Future ↗

May 10, 2023

Via Benzinga

The Latest Analyst Ratings for Clarivate ↗

March 10, 2023

Via Benzinga

Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗

August 22, 2023

Via Benzinga

Topics Artificial Intelligence

Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 ↗

August 07, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 04, 2023

On Friday, 73 companies reached new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗

August 04, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Expert Ratings for Clarivate ↗

January 04, 2023

Via Benzinga

12 Industrials Stocks Moving In Thursday's Intraday Session ↗

August 03, 2023

Via Benzinga

Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts ↗

June 13, 2023

Oppenheimer analyst Owen Lau initiates coverage on Clarivate Plc (NYSE: CLVT) with an Outperform rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023 ↗

June 13, 2023

Via Benzinga

Expert Ratings for Clarivate ↗

November 09, 2022

Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where Clarivate Stands With Analysts ↗

November 09, 2022

Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Analyst Ratings for Clarivate ↗

October 07, 2022

Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter:

Via Benzinga

5 Analysts Have This to Say About Clarivate ↗

September 13, 2022

Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter:

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 08, 2023

On Monday, 61 companies hit new 52-week lows.

Via Benzinga

12 Industrials Stocks Moving In Wednesday's Intraday Session ↗

March 01, 2023

Via Benzinga

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

March 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

What 5 Analyst Ratings Have To Say About Clarivate ↗

August 10, 2022

Analysts have provided the following ratings for Clarivate (NYSE:CLVT) within the last quarter:

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know ↗

September 13, 2022

Morgan Stanley has decided to maintain its Overweight rating of Clarivate (NYSE:CLVT) and lower its price target from $16.00 to $15.00. Shares of Clarivate are trading down 2.75% over the last 24...

Via Benzinga

Recap: Clarivate Q2 Earnings ↗

August 09, 2022

Clarivate (NYSE:CLVT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Singapore's National Library Board Picks Clarivate's Software Solutions To Support LAB25 Initiative ↗

August 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗

February 06, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.